<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0011420'>death</z:hpo> receptor Fas and its physiological ligand (FasL) regulate <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of cancerous cells, thereby functioning as a critical component of the host <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> immunosurveillance system </plain></SENT>
<SENT sid="1" pm="."><plain>To evade Fas-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells often downregulate Fas to acquire an <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-resistant phenotype, which is a hallmark of metastatic human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, targeting Fas resistance is of critical importance in Fas-based <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy and immunotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we demonstrated that epigenetic inhibitors <z:chebi fb="0" ids="50131">decitabine</z:chebi> and vorinostat cooperate to upregulate Fas expression in metastatic human colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="50131">Decitabine</z:chebi> also upregulates BNIP3 and Bik expression, whereas vorinostat decreased Bcl-x(L) expression </plain></SENT>
<SENT sid="5" pm="."><plain>Altered expression of Fas, BNIP3, Bik, and Bcl-x(L) resulted in effective sensitization of the metastatic human colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells to FasL-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Using an experimental <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> mouse model, we further demonstrated that <z:chebi fb="0" ids="50131">decitabine</z:chebi> and vorinostat cooperate to suppress colon <z:mp ids='MP_0002038'>carcinoma</z:mp> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Analysis of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-bearing lung tissues revealed that a large portion of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-infiltrating CD8(+) T cells are FasL(+), and <z:chebi fb="0" ids="50131">decitabine</z:chebi> and vorinostat-mediated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppression efficacy was significantly decreased in Fas(gld) mice compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice, suggesting a critical role for FasL in <z:chebi fb="0" ids="50131">decitabine</z:chebi> and vorinostat-mediated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppression in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>Consistent with their function in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> sensitization, <z:chebi fb="0" ids="50131">decitabine</z:chebi> and vorinostat significantly increased the efficacy of CTL adoptive transfer immunotherapy in an experimental <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> mouse model </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, our data suggest that combined modalities of chemotherapy to sensitize the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell to Fas-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and CTL immunotherapy is an effective approach for the suppression of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
</text></document>